Pascal Furet

Pascal Furet

Novartis Institutes for BioMedical Research - Bhubaneswar / United States
Natural Sciences / Chemical Sciences
AD Scientific Index ID: 4388790
-
person_outline Pascal Furet's MOST POPULAR ARTICLES
1-) Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent in vivo …SM Maira, F Stauffer, J Brueggen, P Furet, C Schnell, C Fritsch, ...Molecular cancer therapeutics 7 (7), 1851-1863, 200812972008
2-) In vivo antitumor activity of NVP-AEW541—a novel, potent, and selective inhibitor of the IGF-IR kinaseC Garcı́a-Echeverrı́a, MA Pearson, A Marti, T Meyer, J Mestan, ...Cancer cell 5 (3), 231-239, 20046382004
3-) The allosteric inhibitor ABL001 enables dual targeting of BCR–ABL1AA Wylie, J Schoepfer, W Jahnke, SW Cowan-Jacob, A Loo, P Furet, ...Nature 543 (7647), 733-737, 20175302017
4-) Discovery of 3-(2, 6-dichloro-3, 5-dimethoxy-phenyl)-1-{6-[4-(4-ethyl-piperazin-1-yl)-phenylamino]-pyrimidin-4-yl}-1-methyl-urea (NVP-BGJ398), a potent and selective inhibitor …V Guagnano, P Furet, C Spanka, V Bordas, M Le Douget, C Stamm, ...Journal of medicinal chemistry 54 (20), 7066-7083, 20115262011
5-) Strategies toward the design of novel and selective protein tyrosine kinase inhibitorsP Traxler, P FuretPharmacology & therapeutics 82 (2-3), 195-206, 19995231999